On May 22, Citi analyst Paul Lejuez lowered the firm’s price target on Target Corp. (NYSE: TGT) to $94 from $97, keeping a ...

Prothena Corporation (NASDAQ:PRTA) is a clinical-stage neuroscience company that discovers and develops novel therapies for ...

In the span of just 52 weeks, Target (NYSE: TGT) has traded as low as $87.35 per share and as high as $167.40 per share.

It was a hot afternoon in Port Moresby. Kepa Wagi sat under a mango tree near his house in Hohola, wiping sweat from his forehead.

In other words, Target stock is "cheap" when compared to the valuation of the S&P 500, meaning it's merely less expensive ...